SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler, A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications, European Urology, 2014, 65, 1, 115

    CrossRef

  2. 2
    Jason R. Kovac, Michael M. Pan, Larry I. Lipshultz, Dolores J. Lamb, Current state of practice regarding testosterone supplementation therapy in men with prostate cancer, Steroids, 2014, 89, 27

    CrossRef

  3. 3
    Armin E. Heufelder, Ulrich Wetterauer, Aksam Yassin, Ist es „nur“ das Alter oder braucht er Testosteron?, MMW - Fortschritte der Medizin, 2014, 156, 19, 57

    CrossRef

  4. 4
    Michael L. Eisenberg, Shufeng Li, Paul Betts, Danielle Herder, Dolores J. Lamb, Larry I. Lipshultz, Testosterone therapy and cancer risk, BJU International, 2014, 114, 6
  5. 5
    Bruce R. Kava, To Treat or Not to Treat with Testosterone Replacement Therapy: a Contemporary Review of Management of Late-Onset Hypogonadism and Critical Issues Related to Prostate Cancer, Current Urology Reports, 2014, 15, 7

    CrossRef

  6. 6
    S. Studzińska, B. Buszewski, Fast method for the resolution and determination of sex steroids in urine, Journal of Chromatography B, 2013, 927, 158

    CrossRef

  7. 7
    Preethi M. Rao, Daniel M. Kelly, T. Hugh Jones, Testosterone and insulin resistance in the metabolic syndrome and T2DM in men, Nature Reviews Endocrinology, 2013, 9, 8, 479

    CrossRef

  8. 8
    B. F. Morrison, M. Reid, W. Madden, A. L. Burnett, Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report, Andrology, 2013, 1, 4
  9. 9
    Jeffrey A. Pearl, Daniel Berhanu, Nathaly François, Puneet Masson, Sherwin Zargaroff, John Cashy, Kevin T. McVary, Testosterone Supplementation does not Worsen Lower Urinary Tract Symptoms, The Journal of Urology, 2013, 190, 5, 1828

    CrossRef